Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas.

Histopathology - 1 Aug 2016

Ikemura Masako, Shibahara Junji, Mukasa Akitake, Takayanagi Shunsaku, Aihara Koki, Saito Nobuhito, Aburatani Hiroyuki, Fukayama Masashi

Abstract excerpt

AIMS: We performed an immunohistochemical analysis of alpha-thalassaemia/mental retardation syndrome X-linked (ATRX) expression in adult diffuse gliomas, with reference to clinicopathological and genetic features, to determine the utility of this analysis in diagnostic practice. METHODS AND RESULTS: A total of 193 adult diffuse gliomas underwent immunohistochemical analysis. In areas in which internal controls,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to DNA Helicases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Neoplasm Grading

Share to Oligodendroglioma

Share to X-linked Nuclear Protein

Source

Identifiers

PMID: 26741321
DOI: 10.1111/his.12927

Genes

ATRX
IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas.PMID 26741321Read ↗

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.Semantic proximity Read ↗

ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset.Semantic proximity Read ↗

Molecular Classification Defines 4 Prognostically Distinct Glioma Groups Irrespective of Diagnosis and GradeSemantic proximity Read ↗

ATRX immunostaining predicts IDH and H3F3A status in gliomasSemantic proximity Read ↗

ATRX loss in glioneuronal tumors with neuropil-like islands indicates similarity to diffuse astrocytic tumors.Semantic proximity Read ↗

Practice of IDH1, ATRX, and P53 Immunohistochemistry in Integrated Diagnosis of Adult Diffuse Gliomas: Single Center Study.Semantic proximity Read ↗

Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomasSemantic proximity Read ↗

IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over.Semantic proximity Read ↗

ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients.Semantic proximity Read ↗

ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations.Semantic proximity Read ↗

Expression Profiling of IDH, p53, ATRX, and KI-67 Immunostains as Potential Grid for Molecular Subtyping of Adult Diffuse Gliomas from PakistanSemantic proximity Read ↗

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.